MBrace Therapeutics

Translating Innovative ADC Discovery into Transformative Therapies for Cancer Patients

San Diego, United States · $114.0M raised

Business Model
B2B
Total Funding
$114.0M
Last Round
$85.0M Series BNov 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

MBrace Therapeutics translates innovative antibody-drug conjugate discovery into transformative therapies for cancer patients. The company uses an integrative drug-development approach that combines researchers, physicians, and its development team to advance novel oncology treatments. Its clinical programs include ADC candidates MBRC-101 and MBRC-201. Each member of the team has been impacted by cancer, and that experience underpins a commitment to translate research into new treatment options for patients.

Summary

MBrace Therapeutics is a Biotech company based in San Diego, United States. It has raised $114.0M in total across 3 rounds, most recently a $85.0M Series B round in Nov 2023. Investors include Venrock, TPG Life Sciences Innovation and Avidity Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BNov 2023
$85.0M

Sign up to see all 3 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MBrace Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mbrace-therapeutics"><img src="https://indexed.vc/api/badge/company/mbrace-therapeutics" alt="MBrace Therapeutics on Indexed.vc" width="260" height="76" /></a>